01.24.2022

SonoMotion treats its 40th subject in the Break Wave Feasibility First-In-Human clinical trial.

10.01.2021

SonoMotion secures a $400,000 Commercial Readiness Program (CRP) SBIR grant from the NIH.

11.07.2019

SonoMotion closes $10M Series-B round co-led by Advance MedTech Holdings Pte. Ltd., MedVenture Partners Inc and BioVentures. Link to press release.

08.20.2019

SonoMotion initiates First-In-Human clinical trial of its Break Wave™ stone fragmentation system.

05.01.2019

SonoMotion secures a $3M SBIR Phase IIB grant from the NIH in support of its Break Wave™ First-In-Human clinical trial. Planned sites include UW, UBC, UCSD, Cleveland Clinic and Chesapeake Urology.